Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra A Tonetti

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|February 25, 2010
Gene expression patterns in the human breast after pregnancySzilard Asztalos, Peter H Gann, Meghan K Hayes, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 25, 2003
Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cellsDebra A Tonetti, Robyn Rubenstein, Michael DeLeon, et al.
Journal of Medicinal Chemistry|January 25, 2017
Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast CancerRui Xiong, Jiong Zhao, Lauren M Gutgesell, et al.
Molecular Pharmacology|August 14, 2020
Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast CancerBalkees Abderrahman, Philipp Y Maximov, Ramona F Curpan, et al.
Journal of Medicinal Chemistry|May 27, 2020
Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and PalbociclibYangfeng Li, Jiong Zhao, Lauren M Gutgesell, et al.
Cancers|May 28, 2022
Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer CellsPurab Pal, Alec Millner, Svetlana E Semina, et al.
Bioorganic & Medicinal Chemistry|December 25, 2009
Click synthesis of estradiol-cyclodextrin conjugates as cell compartment selective estrogensHye-Yeong Kim, Johann Sohn, Gihani T Wijewickrama, et al.
Molecular Cancer Therapeutics|September 11, 2014
Novel selective estrogen mimics for the treatment of tamoxifen-resistant breast cancerMary Ellen Molloy, Bethany E Perez White, Teshome Gherezghiher, et al.
Springerplus|December 1, 2015
High incidence of triple negative breast cancers following pregnancy and an associated gene expression signatureSzilard Asztalos, Thao N Pham, Peter H Gann, et al.
Oncotarget|August 26, 2014
PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumorsMaoyu Peng, Rajyasree Emmadi, Zebin Wang, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cancer Prevention Research (Philadelphia, Pa.)|February 25, 2010
Gene expression patterns in the human breast after pregnancySzilard Asztalos, Peter H Gann, Meghan K Hayes, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 25, 2003
Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cellsDebra A Tonetti, Robyn Rubenstein, Michael DeLeon, et al.
Journal of Medicinal Chemistry|January 25, 2017
Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast CancerRui Xiong, Jiong Zhao, Lauren M Gutgesell, et al.
Molecular Pharmacology|August 14, 2020
Pharmacology and Molecular Mechanisms of Clinically Relevant Estrogen Estetrol and Estrogen Mimic BMI-135 for the Treatment of Endocrine-Resistant Breast CancerBalkees Abderrahman, Philipp Y Maximov, Ramona F Curpan, et al.
Journal of Medicinal Chemistry|May 27, 2020
Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and PalbociclibYangfeng Li, Jiong Zhao, Lauren M Gutgesell, et al.
Cancers|May 28, 2022
Endocrine Therapy-Resistant Breast Cancer Cells Are More Sensitive to Ceramide Kinase Inhibition and Elevated Ceramide Levels Than Therapy-Sensitive Breast Cancer CellsPurab Pal, Alec Millner, Svetlana E Semina, et al.
Bioorganic & Medicinal Chemistry|December 25, 2009
Click synthesis of estradiol-cyclodextrin conjugates as cell compartment selective estrogensHye-Yeong Kim, Johann Sohn, Gihani T Wijewickrama, et al.
Molecular Cancer Therapeutics|September 11, 2014
Novel selective estrogen mimics for the treatment of tamoxifen-resistant breast cancerMary Ellen Molloy, Bethany E Perez White, Teshome Gherezghiher, et al.
Springerplus|December 1, 2015
High incidence of triple negative breast cancers following pregnancy and an associated gene expression signatureSzilard Asztalos, Thao N Pham, Peter H Gann, et al.
Oncotarget|August 26, 2014
PTK6/BRK is expressed in the normal mammary gland and activated at the plasma membrane in breast tumorsMaoyu Peng, Rajyasree Emmadi, Zebin Wang, et al.
Pageof 3